HKPD HKPD
Company Profile ↓Company Overview
HKPD (HKPD) is a publicly traded company listed on with a market capitalization of $4.51M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 27.2% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2025 Revenue of $20.31M (+21.7% YoY); net profit $-27.06K.
- Trailing 12 Months Year-on-year growth — revenue +21.7%, earnings -102.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 27.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 27.20% |
| 1 Year: | 21.72% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -102.03% |
Stock Price Performance
| 1 Year: | -63.70% |
| 6 Months: | -46.66% |
| 3 Months: | -38.78% |
| 1 Month: | -3.93% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)49.68 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 27.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 76.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Revenue | 12.56M | 16.69M | 20.31M |
| Cost of Revenue | 9.82M | 13.13M | 17.90M |
| Gross Profit | 2.74M | 3.56M | 2.42M |
| Operating Expenses | 1.66M | 1.89M | 2.21M |
| Operating Income | 1.08M | 1.67M | 200.77K |
| EBITDA | 1.76M | 2.53M | 1.21M |
| Interest Expense | 23.24K | 82.77K | 97.67K |
| Pretax Income | 1.02M | 1.53M | 36.11K |
| Tax Provision | 22.57K | 196.25K | 63.17K |
| Net Income | 998.20K | 1.33M | -27.06K |
| Diluted EPS | 0.09 | 0.12 | -0.00 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Total Assets | 3.41M | 8.67M | 9.42M |
| Current Assets | 2.75M | 7.80M | 8.73M |
| Cash & Equivalents | 524.61K | 619.58K | 748.72K |
| Inventory | 190.89K | 933.30K | 559.98K |
| Receivables | 1.65M | 3.70M | 4.66M |
| Total Liabilities | 2.82M | 4.41M | 4.43M |
| Current Liabilities | 2.55M | 3.18M | 2.92M |
| Long Term Debt | 116.86K | 1.12M | 1.50M |
| Total Debt | 691.08K | 2.09M | 2.37M |
| Total Equity | 585.24K | 4.25M | 4.99M |
| Shares Outstanding | 11.00M | 11.00M | 11.00M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating Cash Flow | 1.73M | -394.33K | 569.21K |
| Investing Cash Flow | -132.09K | -40.80K | -2.45M |
| Financing Cash Flow | -1.16M | 537.32K | 2.00M |
| Capital Expenditure | -117.70K | -88.02K | -154.99K |
| Free Cash Flow | 1.61M | -482.35K | 414.23K |
| Net Change in Cash | 439.31K | 102.19K | 109.36K |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Gross Margin % | 21.8% | 21.3% | 11.9% |
| Operating Margin % | 8.6% | 10.0% | 1.0% |
| Net Margin % | 7.9% | 8.0% | -0.1% |
| ROE % | 170.6% | 31.3% | -0.5% |
| ROCE % | 125.7% | 30.5% | 3.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HKPD
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Sahm
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOUHExaFJSX2h6NDlzNnUtTDdCMldWQk9BdW9QaXBLT1AtN2JXM3dKV3F4Q1JJTTUwU05GbVh3MnlfM1FxamYwSGdSRU5zd21OcEpmazhENVExSEtHM3RSMWhwU21fd2JFOHdQTHRSaS1FRUQ2OUwyYWRmT2FIMkROTWdGOWpobF9uUzYtRn…
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNVzg4MEt2aGV2dXN3RlhYN05CUF9CY284MjZHaHdMWUNkdjdFWHpoVE1vaTJkeWhmaVRxQnc4Q3lzYXk2TU1WN3RVZm1HNmMwQloxZXpObzQ3QnBfSDRtc0RyTW9WQ2lBQ1UzZGJ3V0RGQ1k2RVN6cEVQUUpHZjZOLVBKVWtWZkRqLVoxRX…
Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Income Statement - TradingKey
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE1YcnRKVXJfZXU5TUZsRVVwd0JIX2x5SGVSamVBWlp0RlRVZm50RHNDek1zUkdGMjl1ZmtkSEVzNG9oLUgxUjR6STdzUHplWnY0R2JTY0xQS0lxaVZhV00zc0l0eldmTUoxVkVSMC1oang?oc=5" target="_blank">Hong Kong Pharma…
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility Persists - Scalping Stock Signals - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQdmo2SVFjbF9BVEQtUE41dW9QTGw5N3Q3WjJiaFRwQ2o4Qkp0UFBtUGh6LXlob3pKdFBkSWlJR0pXRnpKQmJnd0pzclY3aG9UdV9NVGFrTXM2UFhYTGljLXJHd1NEV051R1VlX3E5ajlndEtjYU5jTGVoUUkySWRBX0tqSXlhb18wcTViU0…
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility Persists - Stock Picks - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNamtNZXdoMDhzWFFud1d0UlVxeHBtSVRCOURXa1VMdk9qemZYMUhHbWJzYnd3TWRGakVyUmFiam91ZWNnbTZiZjlyNGdZRG5WekVwMVlqT29qSi1FVkd4NFFJTTVqRGlndUVJSk9fXy1DWlFudmNrLWp0UHQzUGptbE5fdHRFb3FiZXRtbj…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1wMnpmZjRSQ3ZnWGg0WHJicV9IRG44em1PakpLcV9JQkJ4Y2JfNzBEbFpNMzdSMzNMNERZYzVFSHhROEQwRDNiX0t0YWs2SVdO?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
HKPD — Frequently Asked Questions
What is the current share price of HKPD?
As of 2026-08-05 17:25 PDT, HKPD trades at $0.41 on NASDAQ/NYSE. Its 52-week range is $0.33 to $1.74.
What is the market capitalisation of HKPD?
HKPD has a market capitalisation of $4.51M on NASDAQ/NYSE.
What is the P/E ratio of HKPD?
HKPD trades at a trailing price-to-earnings (P/E) ratio of -136.67. Its price-to-book (P/B) ratio is 0.90.
What is the return on equity (ROE) of HKPD?
HKPD has a return on equity (ROE) of -0.54%. Its return on capital employed (ROCE) is 3.09%.
Is HKPD a good stock to buy?
This page provides a data-driven analysis of HKPD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.